Syndax Pharmaceuticals, Inc. (SNDX)

20.56 -0.12 (-0.58%) USD  |  NASDAQ  |  Sep 04, 16:00
20.58 +0.02 (+0.07%) After-Hours: 20:00
More

Syndax Pharmaceuticals SG&A Expense (TTM) : 173.97M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SNDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 173.97M
March 31, 2026 176.24M
December 31, 2025 179.68M
September 30, 2025 167.44M
June 30, 2025 153.63M
March 31, 2025 138.89M
December 31, 2024 120.88M
September 30, 2024 105.97M
June 30, 2024 92.13M
March 31, 2024 77.98M
December 31, 2023 66.92M
September 30, 2023 54.34M
June 30, 2023 45.31M
March 31, 2023 38.38M
December 31, 2022 33.26M
September 30, 2022 29.99M
June 30, 2022 28.55M
March 31, 2022 26.41M
December 31, 2021 25.24M
September 30, 2021 23.03M
June 30, 2021 22.06M
March 31, 2021 22.26M
December 31, 2020 22.50M
September 30, 2020 22.87M
Date Value
June 30, 2020 20.65M
March 31, 2020 18.07M
December 31, 2019 16.06M
September 30, 2019 14.87M
June 30, 2019 15.39M
March 31, 2019 16.41M
December 31, 2018 17.29M
September 30, 2018 17.48M
June 30, 2018 16.92M
March 31, 2018 16.72M
December 31, 2017 15.86M
September 30, 2017 14.75M
June 30, 2017 14.46M
March 31, 2017 12.98M
December 31, 2016 13.32M
September 30, 2016 16.38M
June 30, 2016 13.11M
March 31, 2016 12.14M
September 30, 2014 9.693M
June 30, 2014 3.666M
March 31, 2014 4.404M
December 31, 2013 2.558M
September 30, 2013 0.738M
March 31, 2013 0.738M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Viking Therapeutics, Inc. 50.70M
Kura Oncology, Inc. 135.28M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M